Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy

doi:10.3748/wjg.v30.i37.4132

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1714)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-7) series.

Item

Count

PDF

HTML

1133

Figures (1-5)

Tables (1-7)

Sum=1325

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

123

Sum=209

Publishing Process of This Article

Item

Count

Browse

Download

Sum=123

Oct 7, 2024 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 7, 2024; 30(37): 4132-4148
Published online Oct 7, 2024. doi: 10.3748/wjg.v30.i37.4132

Table 3 Cox subgroup analyses of the prognostic factors for progression-free survival and overall survival based on body mass index

BMI group	HR (95%CI)
Overall survival
18.5-24.9	1 (Reference)
25.0-29.9	0.48 (0.25-0.90)
≥ 30.0	0.28 (0.14-0.57)
P value	0.002
Progression-free survival
18.5-24.9	1 (Reference)
25.0-29.9	0.36 (0.19-0.69)
≥ 30.0	0.13 (0.06-0.31)
P value	< 0.001

BMI: Body mass index; HR: Hazard ratio; CI: Confidence interval.

Citation: Wang YQ, Pan D, Yao ZY, Li YQ, Qu PF, Wang RB, Gu QH, Jiang J, Han ZX, Liu HN. Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy. World J Gastroenterol 2024; 30(37): 4132-4148
URL: https://www.wjgnet.com/1007-9327/full/v30/i37/4132.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i37.4132